KORU Medical Systems, Inc. (NASDAQ:KRMD)

Thursday, March 13, 2025 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($3.28; $150.3M market cap), announced Q4 2024 results: Q4...
Monday, January 13, 2025 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($3.96; $181.9M market cap), announced preliminary Q4 2024 results: Preliminary,...
Thursday, March 14, 2024 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($2.12; $96.8M market cap), announced Q4 2023 results: Q4 sales of...
See All Research...
Tuesday, October 7, 2014, 9:25 AM
Repro-Med Systems' Focus On The Home-Care Market Could Lead To Substantial Payoff Or Buyout
See All Articles and Reports...
Sunday, January 4, 2026, 12:00 AM
How GeoInvesting is Evolving and Why It Matters [GeoWire Weekly No. 220] | 🇺🇸 MRCR USAQ TXRP
Sunday, December 28, 2025, 2:33 PM
Plant the Seeds, Grow Conviction, Then Commit [GeoWire Weekly No. 219] | 🇺🇸 VELO OPXS
Sunday, December 21, 2025, 3:28 PM
Skull Session with a Revenue-Based Financing Company; Run to $1.00 Model Portfolio Heating Up [GeoWire Weekly No. 218] | 🇺🇸 PXHI LRGR CITR ATGN 🇨🇦 BDT.TO
See All GeoWire Weekly...
KORU Medical Systems develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60(R) and FreedomEdge(R) Syringe Infusion Drivers, Precision Flow Rate Tubing(TM) and HIgH-Flo Subcutaneous Safety Needle Sets(TM) . These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Web site: http://www.repro-med.com

Last updated November 1, 2019


Market Data powered by QuoteMedia. Terms of Use